Eli Lilly Shares Surge Post-FDA Approval
This is a LLY news story, published by Yahoo Finance, that relates primarily to Ebglyss news.
LLY news
For more LLY news, you can click here:
more LLY newsEbglyss news
For more Ebglyss news, you can click here:
more Ebglyss newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Pharmaceutical powerhouse Eli Lilly. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest eczema approval news, eczema treatment opportunity news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
atopic dermatitis medication EbglyssThe Motley Fool
•1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now
72% Informative
Eli Lilly ( NYSE : LLY ) is having a terrific 2024 . Shares have gained 58% so far this year , outperforming both the S&P 500 and Nasdaq Composite indexes.
The company's Alzheimer's drug, donanemab, received approval from the FDA in July .
In September , Lilly received FDA approval for its atopic dermatitis medication Ebglyss .
The $31 billion market for eczema treatment opportunity could reach $8.1 billion by the middle of next decade .
VR Score
59
Informative language
52
Neutral language
14
Article tone
formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
9
Source diversity
3
Affiliate links
no affiliate links